"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Biomerica, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biomerica, Inc.
When Can We Expect A Profit From Biomerica, Inc. (NASDAQ:BMRA)?
- Jul 25th, 2019 9:33 am
Can You Imagine How Chuffed Biomerica's (NASDAQ:BMRA) Shareholders Feel About Its 141% Share Price Gain?
- Jun 19th, 2019 12:28 pm
Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.
- Jun 5th, 2019 6:19 am
Could Biomerica, Inc.'s (NASDAQ:BMRA) Investor Composition Influence The Stock Price?
- Apr 25th, 2019 8:06 am
BMRA: Revenue Slows Although Potential Growth Catalysts on the Horizon. Further Pipeline Progress
- Apr 22nd, 2019 9:00 am
Biomerica Announces Third Quarter Financial Results
- Apr 16th, 2019 7:18 am
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
- Apr 8th, 2019 6:19 am
LD Micro Virtual Conference Is Live, March 12th and 13th
- Mar 12th, 2019 6:45 am
What You Must Know About Biomerica, Inc.’s (NASDAQ:BMRA) Beta Value
- Feb 21st, 2019 12:49 pm
Biomerica Announces Updates for H. Pylori Clinical Studies
- Feb 5th, 2019 6:19 am
An Intrinsic Calculation For Biomerica, Inc. (NASDAQ:BMRA) Shows It’s 32.14% Undervalued
- Jan 22nd, 2019 12:42 pm
BMRA: Q2’19 Results: Asia Continues to Accelerate, Europe Rebounds, U.S. Still Weak But Could Return to Growth
- Jan 21st, 2019 9:00 am
Biomerica Announces Second Quarter Financial Results
- Jan 15th, 2019 6:19 am
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer
- Nov 28th, 2018 6:19 am
Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications
- Nov 16th, 2018 6:55 am
Can We See Significant Insider Ownership On The Biomerica Inc (NASDAQ:BMRA) Share Register?
- Nov 16th, 2018 5:30 am
Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud
- Nov 7th, 2018 7:42 am
BMRA: Q1 2019: Asia Strong, Europe & U.S. Weak. Revenue up 13% QoQ But Down 12% yoy. Expense Control Minimizes Op Loss.
- Oct 22nd, 2018 11:15 am
Is Biomerica Inc (NASDAQ:BMRA) A Financially Sound Company?
- Sep 26th, 2018 10:00 am
Frequently Asked Questions
Terms and Conditions
Copyright © 2019 VentureLine
Website developed by Digital Solutions